Alecensa 150 MG capsule UU 240S
Ended Awarded
- Contract number
- SPE2DB25FDM34
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,346
Award facts
- Contract value 100% obligated
- $58,346.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $58,346.04 to DMS Pharmaceutical Group Inc. on September 28, 2025, for the supply of Alecensa 150 mg capsules (240-count units). This firm fixed-price delivery order, which must be completed by October 20, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor with no identified subcontractors on this award. The delivery will be performed at the contractor's Park Ridge location.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The parent contract, operating under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. Alecensa, a branded oncology medication, represents one of many specialized pharmaceutical products the contractor supplies through this vehicle. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering prescription medications and medical consumables to Department of Defense healthcare sites nationwide.
Quick answers
Who was awarded contract SPE2DB25FDM34?
SPE2DB25FDM34 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 28, 2025.
How much is contract SPE2DB25FDM34 worth?
The government has obligated $58,346 on SPE2DB25FDM34.
Is contract SPE2DB25FDM34 an order under another contract?
Yes. SPE2DB25FDM34 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM34 competed?
The extent of competition for SPE2DB25FDM34 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award